Christopher Gocke

Associate Professor

1992 …2019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Christopher Gocke is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 18 Similar Profiles
Mutation Medicine & Life Sciences
Acute Myeloid Leukemia Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Leukemia Medicine & Life Sciences
Molecular Pathology Medicine & Life Sciences
Bone Marrow Medicine & Life Sciences
Polymerase Chain Reaction Medicine & Life Sciences
DNA Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1992 2019

A phase i trial of the VEGF receptor tyrosine kinase inhibitor pazopanib in combination with the MEK inhibitor trametinib in advanced solid tumors and differentiated thyroid cancers

Kurzrock, R., Ball, D. W., Zahurak, M. L., Nelkin, B. D., Subbiah, V., Ahmed, S., O'Connor, A., Karunsena, E., Parkinson, R., Bishop, J. A., Ha, Y., Sharma, R., Gocke, C., Zinner, R., Rudek-Renaut, M., Sherman, S. I. & Azad, N., Sep 15 2019, In : Clinical Cancer Research. 25, 18, p. 5475-5484 10 p.

Research output: Contribution to journalArticle

Vascular Endothelial Growth Factor Receptor
Mitogen-Activated Protein Kinase Kinases
Thyroid Neoplasms
Protein-Tyrosine Kinases
Neoplasms

Bone Marrow Findings in Patients With Acute Promyelocytic Leukemia Treated With Arsenic Trioxide

Miller, K. P., Venkataraman, G., Gocke, C., Batista, D., Borowitz, M. J., Burns, K., Pratz, K. & Duffield, A. S., Oct 7 2019, In : American journal of clinical pathology. 152, 5, p. 675-685 11 p.

Research output: Contribution to journalArticle

Acute Promyelocytic Leukemia
Tretinoin
Bone Marrow
Megakaryocytes
Biopsy

Clinical mutational profiling and categorization of BRAF mutations in melanomas using next generation sequencing

Lokhandwala, P., Tseng, L. H., Rodriguez, E., Zheng, G., Pallavajjalla, A., Gocke, C., Eshleman, J. & Lin, M-T., Jul 5 2019, In : BMC cancer. 19, 1, 1 p.

Research output: Contribution to journalArticle

Open Access
Melanoma
Mutation
Phosphotransferases
Codon
Incidence

Clinical validation of coexisting activating mutations within EGFR, mitogen-activated protein kinase, and phosphatidylinositol 3-kinase pathways in lung cancers

De Marchi, F., Haley, L., Fryer, H., Ibrahim, J., Beierl, K., Zheng, G., Gocke, C., Eshleman, J., Belchis, D. A., Illei, P. B. & Lin, M-T., Feb 1 2019, In : Archives of Pathology and Laboratory Medicine. 143, 2, p. 174-182 9 p.

Research output: Contribution to journalArticle

Phosphatidylinositol 3-Kinase
Mitogen-Activated Protein Kinases
Epidermal Growth Factor Receptor
Lung Neoplasms
Mutation

Clinical validation of coexisting driver mutations in colorectal cancers

Zheng, G., Tseng, L. H., Haley, L., Ibrahim, J., Bynum, J., Xian, R., Gocke, C., Eshleman, J. & Lin, M-T., Apr 1 2019, In : Human pathology. 86, p. 12-20 9 p.

Research output: Contribution to journalArticle

Colorectal Neoplasms
Mutation
Mitogen-Activated Protein Kinases
Proto-Oncogene Proteins B-raf
Phosphatidylinositol 3-Kinase